Biblio

Found 7 results
Filters: Keyword is Neuroprotective Agents  [Clear All Filters]
2022
Nilles KL, Williams EI, Betterton RD, Davis TP, Ronaldson PT.  2022.  Blood-Brain Barrier Transporters: Opportunities for Therapeutic Development in Ischemic Stroke.. Int J Mol Sci. 23(3)
Stanton JA, Williams EI, Betterton RD, Davis TP, Ronaldson PT.  2022.  Targeting organic cation transporters at the blood-brain barrier to treat ischemic stroke in rats.. Exp Neurol. 357:114181.
2021
Mi Y, Qi G, Brinton RDiaz, Yin F.  2021.  Mitochondria-Targeted Therapeutics for Alzheimer's Disease: The Good, the Bad, the Potential.. Antioxid Redox Signal. 34(8):611-630.
2014
Thompson BJ, Sanchez-Covarrubias L, Slosky LM, Zhang Y, Laracuente M-L, Ronaldson PT.  2014.  Hypoxia/reoxygenation stress signals an increase in organic anion transporting polypeptide 1a4 (Oatp1a4) at the blood-brain barrier: relevance to CNS drug delivery.. J Cereb Blood Flow Metab. 34(4):699-707.
2011
Yao J, Chen S, Cadenas E, Brinton RDiaz.  2011.  Estrogen protection against mitochondrial toxin-induced cell death in hippocampal neurons: antagonism by progesterone.. Brain Res. 1379:2-10.
2008
Foy MR, Baudry M, Brinton RDiaz, Thompson RF.  2008.  Estrogen and hippocampal plasticity in rodent models.. J Alzheimers Dis. 15(4):589-603.
Brinton RDiaz, Thompson RF, Foy MR, Baudry M, Wang J, Finch CE, Morgan TE, Pike CJ, Mack WJ, Stanczyk FZ et al..  2008.  Progesterone receptors: form and function in brain.. Front Neuroendocrinol. 29(2):313-39.